Quick Answer
Pharmagreen Biotech Inc. reported Cash And Cash Equivalents At Carrying Value of $25.3 thousand for the year ending 2021.
- Pharmagreen Biotech Inc. showed an increase of +107.4% in Cash And Cash Equivalents At Carrying Value from 2020 to 2021.
- This data is from Pharmagreen Biotech Inc.'s annual report (Form 10-K), filed with the SEC on December 29, 2021.
- XBRL data for this metric is available from 2019 to 2021 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $12.2 thousand | Q1 2021: $13.5 thousand | Q2 2021: $19.2 thousand | Q3 2021: $25.3 thousand | Q1 2022: $3.0 thousand | Q2 2022: $24.3 thousand.
- Over the full 3 years of available data (2019 to 2021), Pharmagreen Biotech Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 59.6%.
- Historical annual values: Fiscal year 2021: $25.3 thousand | Fiscal year 2020: $12.2 thousand | Fiscal year 2019: $62.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: